亚洲One Health部门外部质量评估计划覆盖、可用性与参与情况
该研究通过桌面审查、在线调查和访谈评估亚洲国家参考实验室在One Health各部门的外部质量评估(EQA)覆盖情况。EQA覆盖在国家和部门间差异显著,建议引入覆盖One Health部门的综合高质量EQA计划。
要点
- 亚洲One Health部门EQA覆盖异质,人类健康与动物/食品安全实验室参与度不同。
- 31个参考实验室中7个未参与任何EQA计划,其中2个不开展微生物学检测。
- 仅1个国际EQA提供方服务所有One Health部门,需整合高质量EQA计划。
核心结论
- 亚洲One Health部门抗微生物药物耐药性(AMR)实验室EQA覆盖在国家间及部门间呈异质性。
- 引入覆盖One Health部门的综合高质量EQA计划具有益处和相关性。
研究设计与样本
- 通过桌面审查、在线调查和访谈评估EQA参与方和提供方。
- 纳入31个国家参考实验室(16个人类健康,15个动物/食品安全)。
主要发现
- 14个人类健康实验室和7个动物/食品安全实验室参与国际EQA计划,部分参与两个或以上不同计划。
- 7个实验室未参与任何EQA计划,其中1个人类健康和1个动物/食品安全实验室不开展微生物学检测。
- 6个人类健康国家参考实验室提供国家EQA。
- 8个被调查的国际EQA提供方中3个位于亚洲,所有提供方在病原体、频率和支持机制上提供不同计划。
- 仅1个提供方服务所有One Health部门实验室。
临床怎么用
- 应关注One Health部门EQA覆盖差异,推动跨部门综合EQA计划以提升AMR实验室监测能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Establishing effective external quality assessment (EQA) programmes is an important element in ensuring the quality of, and building capacity for, antimicrobial resistance (AMR) laboratory surveillance. OBJECTIVES: To understand the current coverage of, and challenges to participation in, EQAs in National Reference Laboratories (NRLs) across One Health (OH) sectors in Asia. METHODS: Current EQA coverage was evaluated through desktop review, online surveys and interviews of both EQA participants and providers. EQA coverage was mapped and summarized by laboratory type and 'readiness' level and identified challenges evaluated qualitatively. RESULTS: Of the 31 identified NRLs [16 Human Health (HH) and 15 Animal/Food Safety laboratories (A/FS)], 14 HH and 7 A/FS laboratories currently participated in international EQA schemes and several participated in two or more different schemes. Seven laboratories were currently not participating in any EQA scheme and two of these (one HH and one A/FS) do not currently perform microbiology; six HH NRLs provided national EQAs. Of the eight surveyed international EQA providers, three were based in Asia and all offered varying programmes in terms of pathogens, frequency and support mechanisms for reporting and follow-up. Only one provider currently served laboratories across all OH sectors. CONCLUSIONS: The current coverage of EQA programmes for AMR in Asia was heterogeneous across countries but especially across OH sectors. This updated overview of the coverage and challenges associated with participation in, and provision of, EQAs for AMR suggest the benefit and relevance of introducing one comprehensive and high-quality EQA programme across OH sectors in Asia.
引用
- Mogeni OD, Abegaz FA, Kim JH, et al. Mapping the coverage, availability and uptake of External Quality Assessment programmes across One Health sectors in Asia. J Antimicrob Chemother. 2021. PMID: 34568941. doi:10.1093/jac/dkab354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。